Table 1 Patients’ characteristics
Characteristic | 8MW0511 (N = 328) | PEG-rhG-CSF (N = 164) | Total (N = 492) |
|---|---|---|---|
Age, years | |||
Median | 51.0 | 52.0 | 51.5 |
Min, Max | 27, 70 | 26, 70 | 26, 70 |
Sex, N(%) | |||
Female | 328 (100.0) | 164 (100.0) | 492 (100.0) |
Height(cm) | |||
Mean ± SD) | 158.7 ± 5.5 | 158.5 ± 5.1 | 158.6 ± 5.4 |
Min, Max | 140,176 | 143,172 | 140,176 |
Weight(kg) | |||
Mean ± SD | 62.1 ± 9.6 | 61.7 ± 10.1 | 62.0 ± 9.7 |
Min, Max | 45, 112 | 46, 123.7 | 45, 123.7 |
Body areas(m2) | |||
Mean ± SD | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.6 ± 0.1 |
Min, Max | 1.3, 2.2 | 1.3, 2.3 | 1.3, 2.3 |
Cancer stage, N(%) | |||
early | 257 (78.4) | 131 (79.9) | 388 (78.9) |
advanced | 71 (21.6) | 33 (20.1) | 104 (21.1) |
Metastasis, N(%) | |||
Yes | 152 (46.3) | 75 (45.7) | 227 (46.1) |
No | 176 (53.7) | 89 (54.3) | 265 (53.9) |
Baseline ANC, (109/L) | |||
Mean ± SD | 4.14 ± 1.49 | 4.16 ± 1.63 | 4.14 ± 1.53 |
Min, Max | 2.02, 12.91 | 2.04, 11.58 | 2.02, 12.91 |
Chemotherapy, N(%) | |||
TC | 204 (62.2) | 101 (61.6) | 305 (62.0) |
TAC | 124 (37.8) | 63 (38.4) | 187 (38.0) |